Desmethyl Bosentan

Catalog No. :
ACDURK438
CAS No. :
253688-61-8
Molecular Formula :
C26H27N5O6S
Molecular Weight :
537.60

IUPAC Name:4-(tert-butyl)-N-(6-(2-hydroxyethoxy)-5-(2-hydroxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide

Desmethyl Bosentan structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDesmethyl Bosentan
IUPAC Name4-(tert-butyl)-N-(6-(2-hydroxyethoxy)-5-(2-hydroxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide
Molecular FormulaC26H27N5O6S
Molecular Weight537.60
SMILESO=S(C1=CC=C(C(C)(C)C)C=C1)(NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC4=CC=CC=C4O)=O
InChI KeySTTLKJGYAWXIPP-UHFFFAOYSA-N
Synonym4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-hydroxyphenoxy)[2,2bipyrimidin]-4-yl]benzenesulfonamide;Bosentan O-DesMethyl IMpurity;O-Desmethyl Bosentan;Bosentan O-Desmethyl-Imp;Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-hydroxyphenoxy)[2,2'-bipyrimidin]-4-yl]-;Desmethyl BosentanQ: What is Desmethyl Bosentan Q: What is the CAS Number of Desmethyl Bosentan Q: What is the storage condition of Desmethyl Bosentan Q: What are the applications of Desmethyl Bosentan;4-(tert-butyl)-N-(6-(2-hydroxyethoxy)-5-(2-hydroxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide
CAS No.253688-61-8

Synthetic Route by SureRoute

1. ACDURK438 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDURK438 route product structure diagram
    ACDURK438253688-61-8
Inquiry

2. ACDURK438 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDURK438 route product structure diagram
    ACDURK438253688-61-8
Inquiry

Comments (0)